Lung cancer kills more people than any other cancer in the world. In 2022, it caused 1.8 million deaths globally, accounting for 18.7% of all cancer deaths. That’s roughly double the death toll of the next deadliest cancer, colorectal cancer, which killed about 900,000 people the same year.
The Five Deadliest Cancers Worldwide
The World Health Organization’s most recent global cancer data ranks the top five cancers by death toll:
- Lung cancer: 1.8 million deaths (18.7% of all cancer deaths)
- Colorectal cancer: 900,000 deaths (9.3%)
- Liver cancer: 760,000 deaths (7.8%)
- Breast cancer: 670,000 deaths (6.9%)
- Stomach cancer: 660,000 deaths (6.8%)
Together, these five cancers account for nearly half of all cancer deaths on the planet. Lung cancer alone kills more people than liver and stomach cancer combined.
Why Lung Cancer Is So Deadly
Lung cancer’s lethality comes down to one core problem: it’s rarely caught early. The lungs have no pain receptors in most of their tissue, so tumors can grow for months or years without causing obvious symptoms. Early signs like a persistent cough, mild shortness of breath, or fatigue are easy to dismiss or attribute to something else entirely.
This is especially true for people with existing respiratory conditions. Research has found that conditions like COPD and asthma can mask early lung cancer symptoms, delaying diagnosis. Patients with one such condition were diagnosed an average of 31 days later than those without. Patients with two or more overlapping conditions faced delays averaging 74 days. COPD alone was linked to a 59-day delay. Those weeks and months matter enormously, because lung cancer can shift from a treatable stage to an advanced one in that window.
Screening can close that gap. In clinical trials, annual low-dose CT scans for high-risk individuals (heavy smokers and recent former smokers aged 55 to 74) reduced lung cancer deaths by 20 to 24% compared to those who weren’t screened or received only standard chest X-rays. Despite this, most people who qualify for screening don’t get it. Fewer than 1 in 5 eligible adults in the U.S. undergo annual lung cancer screening.
The Rankings Differ for Men and Women
Cancer doesn’t kill men and women in the same order. In 2022, cancer claimed 5.4 million male lives and 4.3 million female lives worldwide. The top three causes of cancer death for each group look different:
For men, lung cancer is the clear leader, followed by liver cancer and then colorectal cancer. For women, breast cancer is the top killer, followed by lung cancer and colorectal cancer. Colorectal cancer appears in the top three for both sexes, making it one of the most consistently deadly cancers regardless of gender.
Colorectal Cancer Is Rising in Younger Adults
One of the more alarming trends in cancer mortality is what’s happening with colorectal cancer in people under 50. Death rates in this age group have been climbing by about 1% per year since 2004. That stands in sharp contrast to every other common cancer in younger adults, including breast, lung, and prostate, all of which have seen declining death rates over the same period.
The reasons aren’t fully understood, but the trend has prompted changes in screening guidelines. Routine colonoscopy screening now starts at age 45 in the United States, down from the previous recommendation of 50. Catching precancerous growths early, before they turn malignant, is one of the most effective ways to prevent colorectal cancer deaths altogether.
Death Toll vs. Survival Rate
The cancers that kill the most people overall aren’t necessarily the ones with the lowest survival rates. Total deaths reflect both how common a cancer is and how lethal it is. Lung cancer ranks first in deaths partly because it’s extremely common, diagnosed in over 2.5 million people per year worldwide.
Pancreatic cancer, by contrast, is far less common but has a much worse prognosis on an individual level. Its five-year survival rate is just 13.7%, making it one of the hardest cancers to survive. Like lung cancer, pancreatic cancer is difficult to detect early. The pancreas sits deep in the abdomen, and tumors there rarely cause symptoms until the cancer has already spread. When it’s caught early and still localized, survival rates are significantly higher, but that happens in a minority of cases.
So the answer to “which cancer kills the most people” (lung) is different from “which cancer is hardest to survive” (pancreatic). Both questions matter, but they measure different things.
Why These Numbers Keep Growing
Global cancer deaths are rising, driven by population growth, aging, and lifestyle factors that increase risk. Tobacco use remains the single largest contributor to cancer deaths worldwide, responsible for the majority of lung cancer cases. But obesity, alcohol consumption, air pollution, and physical inactivity also play significant roles across multiple cancer types.
Low- and middle-income countries bear a disproportionate share of the burden. These regions often lack screening infrastructure, early detection programs, and access to treatment, which means cancers that are survivable in wealthier countries prove fatal more often. Liver and stomach cancers, for instance, are heavily concentrated in parts of East Asia and sub-Saharan Africa, where infection-related risk factors like hepatitis and certain bacteria are more prevalent and less likely to be treated before cancer develops.